Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Lin Shao-Lee Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 4 Lin Shao-Lee (CEO) has filed a Form 4 on ACELYRIN, Inc.
Txns: Disposed of 1,161,747 shares @ $0
Acquired 132,236 shares @ $0
08/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/19/2023 4 Lin Shao-Lee (Director) has filed a Form 4 on Surrozen, Inc./DE
Txns: Granted 20,000 options to buy @ $0.56, valued at $11.2k
05/11/2023 4 Lin Shao-Lee (CEO) has filed a Form 4 on ACELYRIN, Inc.
Txns: Converted 1,161,747 shares @ $0
Disposed of 1,107,213 shares @ $0
Acquired 1,107,213 shares @ $0
Paid exercise price by delivering 337,179 shares @ $24.69, valued at $8.3M
Disposed of 677,813 shares @ $0
Acquired 677,813 shares @ $0
Disposed of 354,969 shares @ $0
Acquired 354,969 shares @ $0
Disposed of 354,969 shares @ $0
Acquired 354,969 shares @ $0
Disposed of 349,898 shares @ $0
05/04/2023 4 Lin Shao-Lee (CEO) has filed a Form 4 on ACELYRIN, Inc.
Txns: Granted 774,788 options to buy @ $18, valued at $13.9M
05/04/2023 3 Lin Shao-Lee (CEO) has filed a Form 3 on ACELYRIN, Inc.
10/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/14/2022 3 Lin Shao-Lee (Director) has filed a Form 3 on Third Harmonic Bio, Inc.
06/09/2022 4 Lin Shao-Lee (Director) has filed a Form 4 on Surrozen, Inc./DE
Txns: Granted 20,000 options to buy @ $2.79, valued at $55.8k
08/16/2021 3 Lin Shao-Lee (Director) has filed a Form 3 on Surrozen, Inc./DE
09/28/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2020 4 Lin Shao-Lee (Director) has filed a Form 4 on Principia Biopharma Inc.
Txns: Granted 10,240 options to buy @ $62.66, valued at $641.6k
01/23/2020 4 Lin Shao-Lee (EVP, Head of R&D and CSO) has filed a Form 4 on Horizon Therapeutics Public Ltd Co
Txns: Granted 6,129 shares @ $0
Paid exercise price by delivering 2,716 shares @ $38.25, valued at $103.9k
Granted 12,262 options to buy @ $0
01/07/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/11/2019 4 Lin Shao-Lee (Director) has filed a Form 4 on Principia Biopharma Inc.
Txns: Granted 10,240 options to buy @ $31.77, valued at $325.3k
04/18/2019 4 Lin Shao-Lee (Director) has filed a Form 4 on Principia Biopharma Inc.
Txns: Granted 20,475 options to buy @ $27.81, valued at $569.4k
04/18/2019 3 Lin Shao-Lee (Director) has filed a Form 3 on Principia Biopharma Inc.
02/22/2019 4 Lin Shao-Lee (EVP, Head of R&D and CSO) has filed a Form 4 on Horizon Pharma plc
Txns: Granted 35,652 shares @ $0
Paid exercise price by delivering 15,795 shares @ $21.54, valued at $340.2k
01/08/2019 4 Lin Shao-Lee (EVP, Head of R&D and CSO) has filed a Form 4 on Horizon Pharma plc
Txns: Paid exercise price by delivering 8,242 shares @ $20.39, valued at $168.1k
Paid exercise price by delivering 14,337 shares @ $20.39, valued at $292.3k
Exercised 17,891 restricted stock units @ $0
Granted 53,948 restricted stock units @ $0
Exercised 32,362 restricted stock units @ $0
05/07/2018 4 Lin Shao-Lee (EVP, Head of R&D and CSO) has filed a Form 4 on Horizon Pharma plc
Txns: Granted 97,087 restricted stock units @ $0
01/05/2018 4 Lin Shao-Lee (EVP, Head of R&D and CSO) has filed a Form 4 on Horizon Pharma plc
Txns: Granted 146,685 options to buy @ $15.37, valued at $2.3M
Granted 71,567 restricted stock units @ $0
01/05/2018 3 Lin Shao-Lee (EVP, Head of R&D and CSO) has filed a Form 3 on Horizon Pharma plc

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy